Literature DB >> 4094362

[Carotinoid retinopathy. II. Electrophysiologic findings in 23 carotenoid-treated patients].

U Weber, R Hennekes, G Goerz.   

Abstract

Twenty-three patients on long-term therapy (up to 14 years) with carotenoids (up to 336 g) were tested electrophysiologically. The EOG revealed a small but not significant delay of the light peak. Arden's ratio, however, was normal. The ERG was depressed as far as photopic activity was concerned. At low dosages of carotenoids the scotopic ERG amplitudes were found to be hypernormal, whereas at higher dosages the increase in amplitude during dark-adaptation was markedly delayed. There was a dose-dependent prolongation of b-wave implicit time and a dose-dependent reduction in oscillatory potentials. The marked effect on the b-wave and on the oscillatory potentials and the site of the retinal crystals permit the assumption that a mechanism of carotenoid action is located in the middle layers of the retina.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4094362     DOI: 10.1055/s-2008-1054387

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis.

Authors:  B Daicker; K Schiedt; J J Adnet; P Bermond
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  Experimental carotenoid retinopathy. I. Functional and morphological alterations of the rabbit retina after 11 months dietary carotenoid application.

Authors:  U Weber; W Kern; G E Novotny; G Goerz; S Hanappel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

3.  Experimental carotenoid retinopathy. II. Functional and morphological alterations of the rabbit retina after acute canthaxanthin application with small unilamellar phospholipid liposomes.

Authors:  U Weber; L Michaelis; W Kern; G Goerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.